Could a simple ultrasound replace liver biopsies for this rare disease?
NCT ID NCT07492862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a special ultrasound technique, called dynamic contrast-enhanced ultrasound (DCE-US), can diagnose porto-sinusoidal vascular disorder (PSVD) without needing a liver biopsy. Researchers will compare ultrasound images from 100 people with PSVD or cirrhosis to see if blood flow patterns differ. If it works, this painless test could make diagnosis easier and faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- contrast-enhanced ultrasound with VueBox software
- What this could lead to
- If successful, this could provide a noninvasive way to diagnose PSVD, avoiding the need for a liver biopsy.
- What could go wrong
- This is an early exploratory study with only 100 participants, so results may not be conclusive or widely applicable. The technique may not reliably distinguish PSVD from cirrhosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST ENHANCED ULTRASOUND are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, RM, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Can tracking hospital care for liver patients reduce repeat admissions?
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test